FGF6 blocking peptide product blogThe FGF6 fgf6 (Catalog #MBS827988) is a Blocking Peptide produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The FGF6 Blocking Peptide reacts with Human, Mouse, Rat, Bovine, Dog, Porcine, Rabbit, Sheep and may cross-react with other species as described in the data sheet. MyBioSource\'s FGF6 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL). Researchers should empirically determine the suitability of the FGF6 fgf6 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The FGF6 fgf6 product has the following accession number(s) (GI #15147343) (NCBI Accession #NP_066276.2) (Uniprot Accession #P10767). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The peptide is used to block Anti-FGF6 Antibody reactivity.
Quality Control: The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Directions for Use: Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours. FGF6 also interacts with the following gene(s): FGF1, FGF18, FGF19, FGF2, FGF23, FGF7, FGFR2, FGFR3, FGFR4. Muscle, Testis tissues are correlated with this protein. The following patways have been known to be associated with this gene. Atrophy, Breast Neoplasms, Cell Transformation, Neoplastic, Chromosome Aberrations, Hyperplasia, Hypertrophy, Inflammation, Lung Neoplasms, Prostatic Diseases, Urinary Bladder Neoplasms are some of the diseases may be linked to FGF6 Blocking Peptide.